Digvijaya , Mittal S, Mittal P, Singh R, Gupta S, Singh T
Scientifica (Cairo). 2024; 2024:9978076.
PMID: 39618688
PMC: 11606658.
DOI: 10.1155/2024/9978076.
Tang Y, Ju W, Liu Y, Deng Q
Front Pharmacol. 2024; 15:1469830.
PMID: 39403142
PMC: 11471651.
DOI: 10.3389/fphar.2024.1469830.
Zang C, Tian Y, Tang Y, Tang M, Yang D, Chen F
J Transl Med. 2024; 22(1):879.
PMID: 39350207
PMC: 11440768.
DOI: 10.1186/s12967-024-05490-3.
Ostergaard A, Fiocco M, de Groot-Kruseman H, Moorman A, Vora A, Zimmermann M
Leukemia. 2024; 38(7):1477-1487.
PMID: 38844578
PMC: 11216990.
DOI: 10.1038/s41375-024-02287-7.
Dong X, Zhang J
Toxicol Rep. 2024; 12:430-435.
PMID: 38618137
PMC: 11015445.
DOI: 10.1016/j.toxrep.2024.04.001.
Ultrasensitive Response Explains the Benefit of Combination Chemotherapy Despite Drug Antagonism.
Patterson S, Pomeroy A, Palmer A
Mol Cancer Ther. 2024; 23(7):995-1009.
PMID: 38530117
PMC: 11219261.
DOI: 10.1158/1535-7163.MCT-23-0642.
Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study.
Huot L, Guerre P, Descotes G, Caffin A, Herledan C, Ranchon F
BMJ Open. 2024; 14(2):e074956.
PMID: 38367968
PMC: 10875583.
DOI: 10.1136/bmjopen-2023-074956.
Association of chemotherapy dose intensity and age with outcomes in patients with Ewing's family sarcoma.
Klingberg D, Bae S, Zhou D, Sim H, Cai R, Anazodo A
Asia Pac J Clin Oncol. 2023; 21(1):87-94.
PMID: 37566390
PMC: 11733862.
DOI: 10.1111/ajco.13998.
Cotargeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells.
Hardin H, Dinh C, Huegel J, Petrilli A, Bracho O, Allaf A
Mol Cancer Ther. 2023; 22(11):1280-1289.
PMID: 37527526
PMC: 10832398.
DOI: 10.1158/1535-7163.MCT-23-0135.
How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?.
Mendes I, Vale N
Int J Mol Sci. 2023; 24(14).
PMID: 37511612
PMC: 10380870.
DOI: 10.3390/ijms241411855.
Ferroptosis and its emerging role in tumor.
Wang X, Liu Z, Ma L, Yu H
Biophys Rep. 2023; 7(4):280-294.
PMID: 37287758
PMC: 10233469.
DOI: 10.52601/bpr.2021.210010.
Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma.
Huang J, Chen S, Liao Y, Kao Y, Ho W, Chang H
J Pers Med. 2023; 13(4).
PMID: 37109054
PMC: 10146212.
DOI: 10.3390/jpm13040668.
Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose Intensity.
Fernando I, Lax S, Bowden S, Ahmed I, Steven J, Churn M
Clin Oncol (R Coll Radiol). 2023; 35(6):397-407.
PMID: 37012180
PMC: 10186116.
DOI: 10.1016/j.clon.2023.03.007.
Preclinical evaluation of pentagamavunone-1 as monotherapy and combination therapy for pancreatic cancer in multiple xenograft models.
Kamitani N, Nakamae I, Yoneda-Kato N, Kato J, Sho M
Sci Rep. 2022; 12(1):22419.
PMID: 36575213
PMC: 9794715.
DOI: 10.1038/s41598-022-26863-y.
Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience.
Alaklabi S, Roy A, Attwood K, George A, OConnor T, Early A
Front Oncol. 2022; 12:1012391.
PMID: 36338738
PMC: 9631302.
DOI: 10.3389/fonc.2022.1012391.
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis.
Breadner D, Loree J, Cheung W, Gipson M, Lakkunarajah S, Mulder K
BMC Cancer. 2022; 22(1):1119.
PMID: 36319973
PMC: 9628061.
DOI: 10.1186/s12885-022-10198-y.
Mitigating acute chemotherapy-associated adverse events in patients with cancer.
Kuderer N, Desai A, Lustberg M, Lyman G
Nat Rev Clin Oncol. 2022; 19(11):681-697.
PMID: 36221000
DOI: 10.1038/s41571-022-00685-3.
Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study.
Yagi Y, Kanemasa Y, Sasaki Y, Ohigashi A, Morita Y, Tamura T
BMC Cancer. 2022; 22(1):640.
PMID: 35690729
PMC: 9188225.
DOI: 10.1186/s12885-022-09734-7.
Clinical and Economic Impact of a Multidisciplinary Follow-Up Program in Lymphoma Patients.
Devaux M, Boulin M, Mounier M, Caillot D, Ahwij N, Herbin A
Cancers (Basel). 2022; 14(10).
PMID: 35626136
PMC: 9139274.
DOI: 10.3390/cancers14102532.
Smart Injectable Chitosan Hydrogels Loaded with 5-Fluorouracil for the Treatment of Breast Cancer.
Abdellatif A, Mohammed A, Saleem I, Alsharidah M, Al Rugaie O, Ahmed F
Pharmaceutics. 2022; 14(3).
PMID: 35336035
PMC: 8950008.
DOI: 10.3390/pharmaceutics14030661.
